News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
265,578 Results
Type
Article (13796)
Company Profile (101)
Press Release (251681)
Multimedia
Podcasts (47)
Webinars (10)
Section
Business (88055)
Career Advice (465)
Deals (15343)
Drug Delivery (67)
Drug Development (36607)
Employer Resources (49)
FDA (6294)
Job Trends (6200)
News (150237)
Policy (14039)
Tag
2024 BioCapital Digital (8)
2024 BioForest Digital (3)
2024 BioForest Standard (1)
2024 BioMidwest Digital (3)
2024 BioMidwest Standard (1)
2024 Bio NC Digital (3)
2024 Bio NC Standard (1)
2024 Biotech Bay Standard (7)
2024 Biotech Beach Digital (4)
2024 Biotech Beach Standard (1)
2024 Genetown Digital (3)
2024 Genetown Standard (3)
2024 Lone Star Bio Digital (2)
2024 Pharm Country Digital (2)
2024 Pharm Country Standard (2)
2025 BioForest Digital (2)
2025 Lone Star Bio Digital (4)
2026 BioCapital Standard (1)
2026 Biotech Bay Standard (1)
2026 Pharm Country Standard (1)
Academia (441)
Accelerated approval (2)
Adcomms (6)
Allergies (32)
Alliances (23224)
ALS (36)
Alzheimer's disease (393)
Antibody-drug conjugate (ADC) (38)
Approvals (6330)
Artificial intelligence (106)
Autoimmune disease (9)
Automation (3)
Bankruptcy (149)
Best Places to Work (4370)
BIOSECURE Act (9)
Biosimilars (57)
Biotechnology (40)
Bladder cancer (20)
Brain cancer (16)
Breast cancer (78)
Cancer (602)
Cardiovascular disease (71)
Career advice (407)
Career pathing (11)
CAR-T (22)
Cell therapy (87)
Cervical cancer (4)
Clinical research (30911)
Collaboration (336)
Compensation (152)
Complete response letters (17)
COVID-19 (757)
CRISPR (20)
C-suite (121)
Cystic fibrosis (37)
Data (625)
Denatured (15)
Depression (9)
Diabetes (78)
Diagnostics (1317)
Diversity (2)
Diversity, equity & inclusion (13)
Drug discovery (60)
Drug pricing (64)
Drug shortages (12)
Duchenne muscular dystrophy (36)
Earnings (32114)
Editorial (12)
Employer branding (4)
Employer resources (43)
Events (37458)
Executive appointments (383)
FDA (6709)
Featured Employer (20)
Friedreich's ataxia (2)
Frontotemporal dementia (1)
Funding (209)
Gene editing (38)
Generative AI (9)
Gene therapy (100)
GLP-1 (347)
Government (1298)
Grass and pollen (2)
Guidances (16)
Healthcare (3564)
Huntington's disease (4)
IgA nephropathy (11)
Immunology and inflammation (34)
Indications (12)
Infectious disease (792)
Inflammatory bowel disease (54)
Inflation Reduction Act (6)
Influenza (14)
Intellectual property (47)
Interviews (59)
IPO (5875)
IRA (29)
Job creations (2050)
Job search strategy (373)
Kidney cancer (6)
Labor market (11)
Layoffs (180)
Leadership (3)
Legal (3433)
Liver cancer (19)
Lung cancer (80)
Lymphoma (53)
Machine learning (1)
Management (16)
Manufacturing (151)
MASH (32)
Medical device (1276)
Medtech (1278)
Mergers & acquisitions (9673)
Metabolic disorders (257)
Multiple sclerosis (20)
NASH (14)
Neurodegenerative disease (24)
Neuropsychiatric disorders (6)
Neuroscience (574)
NextGen: Class of 2025 (1586)
Non-profit (593)
Northern California (702)
Now hiring (7)
Obesity (147)
Opinion (119)
Ovarian cancer (21)
Pain (50)
Pancreatic cancer (13)
Parkinson's disease (46)
Partnered (7)
Patents (115)
Patient recruitment (28)
Peanut (10)
People (28935)
Pharmaceutical (64)
Pharmacy benefit managers (11)
Phase I (8043)
Phase II (13077)
Phase III (11737)
Pipeline (437)
Policy (70)
Postmarket research (1401)
Preclinical (3214)
Press Release (25)
Prostate cancer (46)
Psychedelics (8)
Radiopharmaceuticals (120)
Rare diseases (167)
Real estate (2637)
Recruiting (17)
Regulatory (10107)
Reports (14)
Research institute (565)
Resumes & cover letters (55)
Rett syndrome (1)
RNA editing (2)
RSV (8)
Schizophrenia (36)
Series A (36)
Series B (12)
Service/supplier (3)
Sickle cell disease (32)
Southern California (715)
Special edition (6)
Spinal muscular atrophy (77)
Sponsored (6)
Startups (1628)
State (2)
Stomach cancer (3)
Supply chain (31)
Tariffs (21)
The Weekly (30)
United States (7132)
Vaccines (152)
Venture capitalists (14)
Weight loss (99)
Women's health (8)
Worklife (3)
Date
Today (3)
Last 7 days (175)
Last 30 days (835)
Last 365 days (11813)
2025 (3437)
2024 (12502)
2023 (14246)
2022 (19556)
2021 (20068)
2020 (19032)
2019 (14885)
2018 (11713)
2017 (13888)
2016 (13129)
2015 (15472)
2014 (12419)
2013 (10592)
2012 (11395)
2011 (11922)
2010 (10888)
Location
Africa (313)
Alabama (13)
Alaska (1)
Arizona (55)
Arkansas (3)
Asia (20112)
Australia (2612)
California (1701)
Canada (901)
China (235)
Colorado (67)
Connecticut (67)
Delaware (54)
Europe (39422)
Florida (322)
Georgia (38)
Idaho (9)
Illinois (195)
India (16)
Indiana (133)
Iowa (1)
Japan (91)
Kansas (57)
Kentucky (12)
Louisiana (1)
Maine (2)
Maryland (252)
Massachusetts (1469)
Michigan (30)
Minnesota (93)
Missouri (23)
Montana (8)
Nebraska (6)
Nevada (8)
New Hampshire (6)
New Jersey (761)
New Mexico (7)
New York (499)
North Carolina (386)
North Dakota (2)
Northern California (702)
Ohio (49)
Oklahoma (4)
Oregon (16)
Pennsylvania (436)
Puerto Rico (8)
Rhode Island (9)
South America (502)
South Carolina (2)
Southern California (715)
Tennessee (34)
Texas (227)
Utah (33)
Virginia (72)
Washington D.C. (31)
Washington State (116)
Wisconsin (15)
265,578 Results for "cardurion pharmaceuticals".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Cardurion Pharmaceuticals Appoints Karen Lewis as Chief People Officer
March 20, 2025
·
3 min read
Press Releases
Cardurion Pharmaceuticals Appoints Charlotte Newman as Chief Business Officer
January 8, 2025
·
3 min read
Business
Cardurion Raises $260M to Advance Cardiovascular Assets
Backed by Bain Capital, Cardurion Pharmaceuticals will use the Series B funds to advance two assets for heart failure and other cardiovascular conditions.
July 16, 2024
·
1 min read
·
Tyler Patchen
Press Releases
Cardurion Pharmaceuticals Appoints Ron Renaud to Board of Directors
September 27, 2024
·
3 min read
Press Releases
Cardurion Pharmaceuticals Selected as an Endpoints 11 Most Promising Biotech Company
September 30, 2024
·
2 min read
Genetown
Cardurion Pharmaceuticals to Present at the 42nd Annual J.P. Morgan Healthcare Conference
Cardurion Pharmaceuticals to Present at the 42nd Annual J.P. Morgan Healthcare Conference.
January 5, 2024
·
1 min read
Drug Development
Cardurion Pharmaceuticals Presents Positive Clinical Results from CARDINAL‑HF Phase 2a Clinical Trial of PDE9 Inhibitor in Patients With Heart Failure
Cardurion Pharmaceuticals, Inc. announced the presentation of positive clinical data from CARDINAL‑HF, the first Phase 2 proof-of-concept clinical trial of a phosphodiesterase-9 inhibitor in patients with heart failure.
May 11, 2024
·
8 min read
Business
Cardurion Pharmaceuticals Welcomes Emma Reeve as Independent Board Director and Audit Chair
Cardurion Pharmaceuticals, Inc. today announced the appointment of Emma Reeve as an independent board director and audit chair.
October 4, 2023
·
3 min read
Genetown
Cardurion Pharmaceuticals to Provide Update on CaMKII Inhibitor Program at the American Heart Association’s Scientific Sessions 2023
Cardurion Pharmaceuticals, Inc. today announced that the Company will present preclinical data on its Calcium/Calmodulin-dependent Protein Kinase II (CaMKII) inhibitor program at the American Heart Association’s (AHA) Scientific Sessions 2023.
November 7, 2023
·
3 min read
Business
Cardurion Pharmaceuticals Further Bolsters Leadership Team with Appointment of Stephen Migausky as General Counsel
Cardurion Pharmaceuticals, Inc. today announced the appointment of Stephen Migausky as Senior Vice President and General Counsel.
April 19, 2023
·
2 min read
1 of 26,558
Next
